It’s time for genetic testing of clopidogrel response to move into the mainstream, suggests a new scientific statement from the American Heart Association (AHA) that outlines the supporting evidence ...
A year and a half ago, Albert Freund was on his way to work and began feeling a slight pain in his chest, which grew worse. “I broke out into a sweat and the pain got real stiff in my arm,” he said.
LONDON, May 11 (Reuters) - AstraZeneca Plc's experimental heart drug Brilinta has beaten Sanofi-Aventis SA and Bristol-Myers Squibb Co's blockbuster Plavix in a pivotal clinical trial, lifting its ...
BARCELONA (Reuters) - AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening ...
Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...
DEAR DR. ROACH: I have been taking Plavix (clopidogrel) for 15 years because of a mild heart attack that resulted in three stents. Next month, I am having a prostate MRI and biopsy. The urologist told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results